AstraZeneca shares gain after releasing slew of positive drug updates
- Breast cancer drug Enhertu granted US priority review- EU marketing recommendation for asthma drug Tezspire- Ultomiris, a treatment for rare autoimmune disease receives EU marketing approval Pharmaceutical firm AstraZeneca (AZN)...
25 July 2022